Gary L. Norman

Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis

Minoru Nakamura, Hisayoshi Kondo, Tsuyoshi Mori et al. · Hepatology · 2006 · 361 citations · Full text

Medicine, Hematology, Immunology +13

Autoimmune acute liver failure: Proposed clinical and histological criteria

R. Todd Stravitz, Jay H. Lefkowitch, Robert J. Fontana et al. · Hepatology · 2010 · 301 citations · Full text

Medicine, Internal Medicine, Pathology +17

Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial

Philip M. Bath, Polly Scutt, Jason P. Appleton et al. · The Lancet · 2019 · 194 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC

Kentaroh Yamamoto, Hiroshi Imamura, Yutaka Matsuyama et al. · Journal of Gastroenterology · 2010 · 188 citations

Medicine, Pathology, Molecular Pathology +13

Reassessment of Intrinsic Factor and Parietal Cell Autoantibodies in Atrophic Gastritis With Respect to Cobalamin Deficiency

Edith Lahner, Gary L. Norman, Carola Severi et al. · The American Journal of Gastroenterology · 2009 · 175 citations

Life Sciences, Immunology, Pathology +17